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CONCLUSIONS
✓ There is evidence about the beneficial effects of stem cells thanks to paracrine secretion and integration into the neuronal circuit that can 
improve motor and cognitive functions of AD, ALS, stroke and SCI in animal models.
✓ Canine models of spontaneous disease could be a great model to study AD and ALS.
✓ The MSCs are the most used cells in the preclinical and clinical trials of the four diseases reviewed.
✓ Most of the completed clinical trials are designed to assess the safety and tolerance of stem cells and not their effectiveness, but due to the 
promising efficiency in preclinical trials and safety results in clinical studies there are many clinical trials underway in advanced stages.
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ALZHEIMER DISEASE (AD)
❖ Preclinical trials
Significant improvement in learning and memory 
Decrease of Aβ protein aggregates
❖ Clinical trials*
Efficacy shown in preclinical trials is not presented
AMYOTROPHIC LATERAL SCLEROSIS (ALS)
❖ Preclinical trials
Improvement in motor functions and lifespan 
Decrease of onset and progression of symptoms
❖ Clinical trials*
Some of them even showed improved motor function and 
slower progression of the disease
STROKE
❖ Preclinical trials
Decrease of lesional size and improved neurological 
functions
❖ Clinical trials*
No significant functional improvement 
Decrease of mortality and lesional size 
SPINAL CORD INJURY (SCI)
❖ Preclinical trials
Parcial recovery of motor and bladder function
Increased axonal regeneration and myelination
❖ Clinical trials*
No significant functional improvement
Increased improvement in acute than in chronic SCI
patients
INTRODUCTION
Stem cells have been studied in a wide spectrum of diseases and
have shown a high therapeutic potential. In the nervous system there
has been a great interest in stem cells as there is no efective cure for
many diseases.
OBJECTIVES
• To review the use of stem cells in therapy of neurological diseases 
with high prevalence in human medicine.
• The role of animals as a model for human counterparts.
STEM CELLS
*Feasible, safe and without adverse effects
CANINE MODELS
Canine 
cognitive dysfunction
Canine 
degenerative myelopathy
FOR HUMAN DISEASES
Alzheimer disease
Amyotrophic Lateral 
Sclerosis
